Non-alcoholic steatohepatitis (NASH) is a progressive disease which results in advancement of liver fibrosis, cirrhosis, and hepatocellular carcinoma, for which [...]
Non-alcoholic fatty liver disease (NAFLD) is the most chronic form of liver disease, which affects about quarter of the [...]
Non-alcoholic fatty liver disease (NAFLD) is a common condition and estimates indicate almost 1 in 4 adults in the [...]
Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
Nonalcoholic steatohepatitis (NASH) is a disease of the liver characterized by inflammation, cell injury and fibrosis. Progression of this [...]
Did you miss our NASH 3D cell culture webinar with Corning and Molecular Devices on October 14th? If [...]
In this webinar, we’ve partnered with Molecular Devices and Corning to present a case study for integrating novel [...]
Liver disease affects millions of people in the United States alone, resulting in tens of thousands of deaths yearly, [...]
The liver is a tantalizing organ to model because of its role in drug metabolism and as a target [...]
Precision-cut tissue slices (PCTS) are thin tissue slices with precise thickness generated from fresh, viable tissues through the use [...]